FAQs
What does Inari do?
Inari Medical, Inc. is a medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases. Inari is focused on solutions that enable the safe removal of large clot volumes from big vessels without the use of thrombolytic drugs. Inari has developed two novel mechanical thrombectomy technology platforms. The FlowTriever System has FDA clearance for the treatment of pulmonary embolism and for thrombectomy in the peripheral vessels. The ClotTriever System has FDA clearance for thrombectomy in the peripheral vessels. Inari was founded in 2013 as a spin-out of Inceptus Medical, a medical device incubator.
On what exchange does Inari trade, and what is the ticker symbol?
Inari trades on the NASDAQ exchange under the ticker symbol “NARI”.
When was Inari's initial public offering?
Inari’s first day of trading was on May 22, 2020.
Where is Inari headquartered?
The Company’s headquarters is located Irvine, CA.
6001 Oak Canyon Ste. 100
Irvine, CA 92618
(877) 923-4747
6001 Oak Canyon Ste. 100
Irvine, CA 92618
(877) 923-4747
Who are members of Inari's Board of Directors?
The biographies of Inari’s directors are available in the Board of Directors section of our Investor Relations website.
Who are members of Inari's management team?
The biographies of Inari’s directors are available in the Management section of our Investor Relations website.
When does Inari's fiscal year end?
Inari’s fiscal year ends December 31st.
Who are Inari's independent registered public accountants?
Inari’s independent auditor is BDO
600 Anton Blvd.
Suite 500
Costa Mesa, CA 92626
600 Anton Blvd.
Suite 500
Costa Mesa, CA 92626
Who is Inari's outside legal counsel?
Inari’s outside legal counsel is Latham & Watkins LLP
Does Inari pay a dividend?
No, Inari does not pay a dividend at this time.
Can shares of Inari be purchased directly through the company?
No, Inari does not offer a direct stock purchase program.
How can I obtain a copy of Inari's SEC filings?
Inari’s quarterly and annual reports and other SEC filings are available by selecting the Financial Information section of our “Investors” page on our website or through SEC’s website.
Who is Inari's transfer agent?
Inari uses American Stock Transfer & Trust Company, LLC as its transfer agent and contact information is provided below.
American Stock Transfer & Trust Company, LLC
Shareholder Services
6201 15th Avenue
Brooklyn, NY 11219
Toll-free: (888) 921-8140
American Stock Transfer & Trust Company, LLC
Shareholder Services
6201 15th Avenue
Brooklyn, NY 11219
Toll-free: (888) 921-8140
When is your next earnings release?
Please see our Events & Presentations section of our website for a listing of upcoming earnings announcements and other key events.
How can I contact Inari's Investor Relations?
You can contact Inari’s Investor Relations via email by clicking here.
Where and when was Inari incorporated?
Inari was formed under the laws of the state of Delaware in July 2011 under the name Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013.
Who underwrote and managed the IPO?
The IPO was underwritten and managed by Bank of America, Morgan Stanley, Wells Fargo, and Canaccord Genuity
How can I update my stockholder information for an address or name change?
If your shares are held in street name (by your broker), you must notify the securities firm holding your stock. If you hold stock certificates in your name, address changes should be submitted in writing by U.S. Mail to our transfer agent:
American Stock Transfer & Trust Company, LLC
Shareholder Services
6201 15th Avenue
Brooklyn, NY 11219
Toll-free: (888) 921-8140
American Stock Transfer & Trust Company, LLC
Shareholder Services
6201 15th Avenue
Brooklyn, NY 11219
Toll-free: (888) 921-8140
Who can I contact if I am a member of the media?
You can contact Inari’s Media Relations via email by clicking here.